期刊文献+

不同剂量前列地尔辅助羟苯磺酸钙对糖尿病肾病患者肾脏功能、炎性细胞因子及氧化应激水平的影响 被引量:17

Effects of Different Doses of Alprostadil Combined with Calcium Hydroxybenzenesulfonate on Renal function, Inflammatory Cytokines and Oxidative Stress in the Patients with Diabetic Nephropathy
下载PDF
导出
摘要 目的研究不同剂量前列地尔辅助羟苯磺酸钙对糖尿病肾病患者肾脏功能、炎性细胞因子及氧化应激水平的影响。方法选取我院2015年1月~2016年6月收治的糖尿病伴。肾病的患者96例,按前列地尔使用的不同剂量分为常规剂量治疗组(n=46)与大剂量治疗组(n=50)。观察不同治疗对两组患者肾脏功能、炎性细胞因子及氧化应激水平的影响。结果治疗前两组炎性细胞因子、肾脏功能、氧化应激相关指标差异不明显(P〉0.05),治疗后两组患者各项指标较治疗前都有明显改善,差异均有统计学意义(P〈0.05),且大剂量治疗组改善程度优于常规剂量治疗组,差异具有统计学意义(P〈0.05)。结论早期较大剂量前列地尔辅助羟苯磺酸钙治疗糖尿病肾病患者,可明显降低炎性细胞因子水平和氧化应激反应,改善肾脏功能,提高治疗质量,值得临床推广。 Objective To study the effects of different doses of alprostadil combined with calcium hydroxybenzenesulfonate on renal function, inflammatory cytokines and oxidative stress in the patients with diabetic nephropathy. Methods 96 Patients with diabetic nephropathy from January in 2015 to June in 2016 in our hospital were selected and were divided into conventional dose group ( n = 46 ) and high dose treatment group ( n = 50). The effects of different treatments on renal function, inflammatory eytokines and oxidative stress of the patients in the two groups were observed. Results There were no significant differences in inflammatory cytokines, renal function and oxidative stress between the two groups before the treatment (P 〉 0. 05 ). After the treatment the indexes in the two groups were significantly lower than those before treatment. There was statistically significant difference ( P 〈 0. 05 ). And the degree of the improvement in the high - dose treatment group was better than that in the conventional dose group ( P 〈 0.05 ). Conclusion Early high doses of alprostadil and calcium hydroxybenzenesulfonate in the treatment of diabetic nephropathy can significantly reduce inflammatory cytokines, decrease oxidative stress and improve renal function so that the quality of the treatment is increased.
作者 王蕊 安建立 朱悦雨 田伊茗 尹福在 陆强 韩改玲 张伟东 付静静 王锐 Wang Rui An Jianli Zhu Yueyu Tian Yiming Yin Fuzai Lu Qiang Han Gailing Zhang Weidong Fu Jingjing(Department of Endocrinology, the First Hospital of Qinhuangdao, Qinhuangdao 066000, Chin)
出处 《国际老年医学杂志》 2017年第5期211-214,共4页 International Journal of Geriatrics
基金 秦皇岛市第一医院青年科研基金(201502A135)
关键词 前列地尔 羟苯磺酸钙 糖尿病肾病 肾脏功能 炎性细胞因子 氧化应激 Alprostadil Calcium hydroxybenzenesulfonate Diabetic nephropathy Renal function Inflammatory cytokines Oxidative stress
  • 相关文献

参考文献6

二级参考文献73

  • 1刘晓城,刘新明.Effect of Calcium Dobesilate on Nephropathy in Type 2 Diabetic Rats[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(1):36-38. 被引量:5
  • 2曲勇,潘振宇,辛颖,杨明,韩文霞,邢海燕,廖琳.前列腺素E1对糖尿病肾病大鼠肾脏细胞凋亡的影响及其机制的研究[J].细胞与分子免疫学杂志,2006,22(6):774-776. 被引量:16
  • 3Jerums G, Allen TJ, Campbell DJ, et al. Long-term comparison between pefindopfil and nifedipine in normotensive patients with type I diabetes and microalbuminuria [JJ. Am J Kidney Dis, 2002, 37(5): 890-9.
  • 4Remuzzi G, Bertani T. Pathophysiology of progressive nephrothies [J]. N Engl J Med, 1998, 339(20): 1448-56.
  • 5Coen DA. Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease[J]. Nephrol Dial Translant, 2004, 19: 778-81.
  • 6廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2001.610-611.
  • 7Nieholls K.Diabetie nephropathy-how might we prevent,re- tard,or cope with it [J]Aust Faro Physician,2005,34 (11): 933-936.
  • 8Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936.
  • 9Sudarsky D, Nikolsky E. Contrast-induced nephropathy in interventional cardiology. Int J Nephrol Renovasc Dis 2011; 4: 85-99.
  • 10Ozhan H, Erden I, Ordu S, Aydin M, Caglar O, Basar C, et al. Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiographyAngiology 2010; 61: 711-714.

共引文献128

同被引文献146

引证文献17

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部